nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Taste altered—Hyoscyamine—pancreatitis	0.0655	0.0697	CcSEcCtD
Salbutamol—Strangury—Hyoscyamine—pancreatitis	0.0552	0.0588	CcSEcCtD
Salbutamol—Mydriasis—Propantheline—pancreatitis	0.0364	0.0388	CcSEcCtD
Salbutamol—Excitement—Hyoscyamine—pancreatitis	0.0303	0.0323	CcSEcCtD
Salbutamol—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.0227	0.0242	CcSEcCtD
Salbutamol—Heartburn—Hyoscyamine—pancreatitis	0.0216	0.023	CcSEcCtD
Salbutamol—Laryngitis—Hyoscyamine—pancreatitis	0.0206	0.022	CcSEcCtD
Salbutamol—Feeling hot—Hyoscyamine—pancreatitis	0.019	0.0202	CcSEcCtD
Salbutamol—Mydriasis—Hyoscyamine—pancreatitis	0.0187	0.0198	CcSEcCtD
Salbutamol—Abdominal distension—Propantheline—pancreatitis	0.0184	0.0195	CcSEcCtD
Salbutamol—Extrasystoles—Hyoscyamine—pancreatitis	0.0177	0.0188	CcSEcCtD
Salbutamol—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.0165	0.0175	CcSEcCtD
Salbutamol—Drowsiness—Propantheline—pancreatitis	0.0163	0.0173	CcSEcCtD
Salbutamol—Blood pressure increased—Hyoscyamine—pancreatitis	0.0149	0.0158	CcSEcCtD
Salbutamol—Flushing—Propantheline—pancreatitis	0.0135	0.0144	CcSEcCtD
Salbutamol—Pulmonary oedema—Hyoscyamine—pancreatitis	0.0132	0.0141	CcSEcCtD
Salbutamol—Hypertonia—Hyoscyamine—pancreatitis	0.013	0.0139	CcSEcCtD
Salbutamol—Hyperkinesia—Hyoscyamine—pancreatitis	0.013	0.0138	CcSEcCtD
Salbutamol—Tension—Propantheline—pancreatitis	0.0125	0.0133	CcSEcCtD
Salbutamol—Nervousness—Propantheline—pancreatitis	0.0123	0.0131	CcSEcCtD
Salbutamol—Eczema—Hyoscyamine—pancreatitis	0.012	0.0128	CcSEcCtD
Salbutamol—Nasal congestion—Hyoscyamine—pancreatitis	0.0119	0.0126	CcSEcCtD
Salbutamol—Atrial fibrillation—Hyoscyamine—pancreatitis	0.0114	0.0121	CcSEcCtD
Salbutamol—Palpitations—Propantheline—pancreatitis	0.0112	0.0119	CcSEcCtD
Salbutamol—Hypoglycaemia—Hyoscyamine—pancreatitis	0.0111	0.0118	CcSEcCtD
Salbutamol—Dry mouth—Propantheline—pancreatitis	0.0106	0.0113	CcSEcCtD
Salbutamol—Anaphylactic shock—Propantheline—pancreatitis	0.0104	0.011	CcSEcCtD
Salbutamol—Irritability—Hyoscyamine—pancreatitis	0.0103	0.011	CcSEcCtD
Salbutamol—Ataxia—Hyoscyamine—pancreatitis	0.0102	0.0108	CcSEcCtD
Salbutamol—Tachycardia—Propantheline—pancreatitis	0.0101	0.0108	CcSEcCtD
Salbutamol—Hypokalaemia—Hyoscyamine—pancreatitis	0.00983	0.0105	CcSEcCtD
Salbutamol—Abdominal distension—Hyoscyamine—pancreatitis	0.0094	0.01	CcSEcCtD
Salbutamol—Insomnia—Propantheline—pancreatitis	0.00938	0.00998	CcSEcCtD
Salbutamol—Somnolence—Propantheline—pancreatitis	0.00922	0.00981	CcSEcCtD
Salbutamol—Angina pectoris—Hyoscyamine—pancreatitis	0.00909	0.00967	CcSEcCtD
Salbutamol—Constipation—Propantheline—pancreatitis	0.00887	0.00943	CcSEcCtD
Salbutamol—Dysuria—Hyoscyamine—pancreatitis	0.00873	0.00929	CcSEcCtD
Salbutamol—Feeling abnormal—Propantheline—pancreatitis	0.00855	0.00909	CcSEcCtD
Salbutamol—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00842	0.00896	CcSEcCtD
Salbutamol—Drowsiness—Hyoscyamine—pancreatitis	0.00832	0.00885	CcSEcCtD
Salbutamol—Urticaria—Propantheline—pancreatitis	0.00824	0.00876	CcSEcCtD
Salbutamol—Conjunctivitis—Hyoscyamine—pancreatitis	0.00809	0.00861	CcSEcCtD
Salbutamol—Sweating—Hyoscyamine—pancreatitis	0.00798	0.00849	CcSEcCtD
Salbutamol—Hypersensitivity—Propantheline—pancreatitis	0.00764	0.00813	CcSEcCtD
Salbutamol—Asthenia—Propantheline—pancreatitis	0.00744	0.00792	CcSEcCtD
Salbutamol—Clenbuterol—TNF—pancreatitis	0.00696	0.704	CrCbGaD
Salbutamol—Flushing—Hyoscyamine—pancreatitis	0.00693	0.00738	CcSEcCtD
Salbutamol—Dizziness—Propantheline—pancreatitis	0.00686	0.0073	CcSEcCtD
Salbutamol—Arrhythmia—Hyoscyamine—pancreatitis	0.00668	0.0071	CcSEcCtD
Salbutamol—Vomiting—Propantheline—pancreatitis	0.00659	0.00701	CcSEcCtD
Salbutamol—Mental disorder—Hyoscyamine—pancreatitis	0.00655	0.00696	CcSEcCtD
Salbutamol—Rash—Propantheline—pancreatitis	0.00654	0.00696	CcSEcCtD
Salbutamol—Dermatitis—Propantheline—pancreatitis	0.00653	0.00695	CcSEcCtD
Salbutamol—Headache—Propantheline—pancreatitis	0.0065	0.00691	CcSEcCtD
Salbutamol—Tension—Hyoscyamine—pancreatitis	0.00638	0.00679	CcSEcCtD
Salbutamol—Dysgeusia—Hyoscyamine—pancreatitis	0.00637	0.00678	CcSEcCtD
Salbutamol—Nervousness—Hyoscyamine—pancreatitis	0.00632	0.00672	CcSEcCtD
Salbutamol—Nausea—Propantheline—pancreatitis	0.00616	0.00655	CcSEcCtD
Salbutamol—Agitation—Hyoscyamine—pancreatitis	0.00598	0.00636	CcSEcCtD
Salbutamol—Angioedema—Hyoscyamine—pancreatitis	0.00594	0.00632	CcSEcCtD
Salbutamol—Vertigo—Hyoscyamine—pancreatitis	0.00584	0.00622	CcSEcCtD
Salbutamol—Syncope—Hyoscyamine—pancreatitis	0.00583	0.00621	CcSEcCtD
Salbutamol—Palpitations—Hyoscyamine—pancreatitis	0.00575	0.00612	CcSEcCtD
Salbutamol—Loss of consciousness—Hyoscyamine—pancreatitis	0.00572	0.00608	CcSEcCtD
Salbutamol—Chest pain—Hyoscyamine—pancreatitis	0.00554	0.00589	CcSEcCtD
Salbutamol—Anxiety—Hyoscyamine—pancreatitis	0.00552	0.00587	CcSEcCtD
Salbutamol—Dry mouth—Hyoscyamine—pancreatitis	0.00542	0.00576	CcSEcCtD
Salbutamol—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00531	0.00565	CcSEcCtD
Salbutamol—Oedema—Hyoscyamine—pancreatitis	0.00531	0.00565	CcSEcCtD
Salbutamol—Shock—Hyoscyamine—pancreatitis	0.00522	0.00556	CcSEcCtD
Salbutamol—Tachycardia—Hyoscyamine—pancreatitis	0.00518	0.00551	CcSEcCtD
Salbutamol—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00513	0.00546	CcSEcCtD
Salbutamol—Hypotension—Hyoscyamine—pancreatitis	0.00496	0.00528	CcSEcCtD
Salbutamol—Insomnia—Hyoscyamine—pancreatitis	0.0048	0.00511	CcSEcCtD
Salbutamol—Dyspnoea—Hyoscyamine—pancreatitis	0.00473	0.00504	CcSEcCtD
Salbutamol—Somnolence—Hyoscyamine—pancreatitis	0.00472	0.00502	CcSEcCtD
Salbutamol—Dyspepsia—Hyoscyamine—pancreatitis	0.00467	0.00497	CcSEcCtD
Salbutamol—Fatigue—Hyoscyamine—pancreatitis	0.00458	0.00487	CcSEcCtD
Salbutamol—Pain—Hyoscyamine—pancreatitis	0.00454	0.00483	CcSEcCtD
Salbutamol—Constipation—Hyoscyamine—pancreatitis	0.00454	0.00483	CcSEcCtD
Salbutamol—Feeling abnormal—Hyoscyamine—pancreatitis	0.00437	0.00465	CcSEcCtD
Salbutamol—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00434	0.00462	CcSEcCtD
Salbutamol—Urticaria—Hyoscyamine—pancreatitis	0.00422	0.00449	CcSEcCtD
Salbutamol—Body temperature increased—Hyoscyamine—pancreatitis	0.0042	0.00446	CcSEcCtD
Salbutamol—Abdominal pain—Hyoscyamine—pancreatitis	0.0042	0.00446	CcSEcCtD
Salbutamol—Hypersensitivity—Hyoscyamine—pancreatitis	0.00391	0.00416	CcSEcCtD
Salbutamol—Asthenia—Hyoscyamine—pancreatitis	0.00381	0.00405	CcSEcCtD
Salbutamol—Pruritus—Hyoscyamine—pancreatitis	0.00376	0.004	CcSEcCtD
Salbutamol—Diarrhoea—Hyoscyamine—pancreatitis	0.00363	0.00386	CcSEcCtD
Salbutamol—Dizziness—Hyoscyamine—pancreatitis	0.00351	0.00373	CcSEcCtD
Salbutamol—Vomiting—Hyoscyamine—pancreatitis	0.00338	0.00359	CcSEcCtD
Salbutamol—Rash—Hyoscyamine—pancreatitis	0.00335	0.00356	CcSEcCtD
Salbutamol—Dermatitis—Hyoscyamine—pancreatitis	0.00334	0.00356	CcSEcCtD
Salbutamol—Headache—Hyoscyamine—pancreatitis	0.00333	0.00354	CcSEcCtD
Salbutamol—Nausea—Hyoscyamine—pancreatitis	0.00315	0.00335	CcSEcCtD
Salbutamol—Epinephrine—TNF—pancreatitis	0.00292	0.296	CrCbGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000303	0.00605	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.000301	0.00601	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.000301	0.00601	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.000298	0.00595	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000296	0.00591	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.000277	0.00553	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000274	0.00547	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000263	0.00524	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000258	0.00515	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000257	0.00513	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000252	0.00504	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—SCT—pancreatitis	0.000252	0.00503	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CASR—pancreatitis	0.000252	0.00503	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CX3CL1—pancreatitis	0.000247	0.00494	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—SCT—pancreatitis	0.000247	0.00492	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CASR—pancreatitis	0.000247	0.00492	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CX3CL1—pancreatitis	0.000242	0.00483	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—MTNR1B—pancreatitis	0.000241	0.0048	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCK—pancreatitis	0.000241	0.0048	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00024	0.00478	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCK—pancreatitis	0.000235	0.0047	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—MTNR1B—pancreatitis	0.000235	0.0047	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CNR2—pancreatitis	0.000235	0.00468	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—TACR1—pancreatitis	0.000235	0.00468	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.000234	0.00467	CbGpPWpGaD
Salbutamol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000231	0.00462	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCKAR—pancreatitis	0.000231	0.0046	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—TACR1—pancreatitis	0.000229	0.00458	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CNR2—pancreatitis	0.000229	0.00458	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCKAR—pancreatitis	0.000226	0.0045	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.000225	0.00449	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000221	0.00441	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.00022	0.0044	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000216	0.00431	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000207	0.00412	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.000205	0.00409	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.0002	0.004	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—PTHLH—pancreatitis	0.000199	0.00398	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—SMO—pancreatitis	0.000199	0.00398	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—SMO—pancreatitis	0.000195	0.00389	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—PTHLH—pancreatitis	0.000195	0.00389	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PPY—pancreatitis	0.000185	0.00368	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—SST—pancreatitis	0.000182	0.00364	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PPY—pancreatitis	0.000181	0.0036	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—SST—pancreatitis	0.000178	0.00356	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000176	0.00352	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000172	0.00344	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—BDKRB2—pancreatitis	0.000172	0.00342	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000171	0.00342	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CNR1—pancreatitis	0.000168	0.00336	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—BDKRB2—pancreatitis	0.000168	0.00335	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000168	0.00334	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PPY—pancreatitis	0.000168	0.00334	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CNR1—pancreatitis	0.000165	0.00329	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PPY—pancreatitis	0.000164	0.00327	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—GCG—pancreatitis	0.000163	0.00324	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—GCG—pancreatitis	0.000159	0.00317	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—KNG1—pancreatitis	0.000156	0.00311	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—KNG1—pancreatitis	0.000153	0.00304	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000151	0.00301	CbGpPWpGaD
Salbutamol—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000148	0.00296	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000148	0.00295	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000146	0.00291	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—SCT—pancreatitis	0.000143	0.00284	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CASR—pancreatitis	0.000143	0.00284	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—SCT—pancreatitis	0.000139	0.00278	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CASR—pancreatitis	0.000139	0.00278	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCK—pancreatitis	0.000136	0.00271	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—MTNR1B—pancreatitis	0.000136	0.00271	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCK—pancreatitis	0.000133	0.00265	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—MTNR1B—pancreatitis	0.000133	0.00265	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—TACR1—pancreatitis	0.000133	0.00264	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CNR2—pancreatitis	0.000133	0.00264	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCL5—pancreatitis	0.00013	0.0026	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCKAR—pancreatitis	0.00013	0.0026	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CNR2—pancreatitis	0.00013	0.00259	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—TACR1—pancreatitis	0.00013	0.00259	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—SCT—pancreatitis	0.000129	0.00258	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CASR—pancreatitis	0.000129	0.00258	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL5—pancreatitis	0.000128	0.00255	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCKAR—pancreatitis	0.000128	0.00254	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CX3CL1—pancreatitis	0.000127	0.00253	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CASR—pancreatitis	0.000127	0.00253	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—SCT—pancreatitis	0.000127	0.00253	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CX3CL1—pancreatitis	0.000124	0.00248	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCK—pancreatitis	0.000124	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—MTNR1B—pancreatitis	0.000124	0.00246	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCK—pancreatitis	0.000121	0.00241	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—MTNR1B—pancreatitis	0.000121	0.00241	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CNR2—pancreatitis	0.00012	0.0024	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—TACR1—pancreatitis	0.00012	0.0024	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCKAR—pancreatitis	0.000118	0.00236	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000118	0.00235	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CNR2—pancreatitis	0.000118	0.00235	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—TACR1—pancreatitis	0.000118	0.00235	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCKAR—pancreatitis	0.000116	0.00231	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000115	0.0023	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—pancreatitis	0.000115	0.00229	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PTHLH—pancreatitis	0.000113	0.00225	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—pancreatitis	0.000113	0.00224	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PNLIP—pancreatitis	0.00011	0.0022	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PTHLH—pancreatitis	0.00011	0.0022	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PNLIP—pancreatitis	0.000108	0.00215	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—SST—pancreatitis	0.000103	0.00206	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PTHLH—pancreatitis	0.000102	0.00204	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—SMO—pancreatitis	0.000102	0.00204	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—SST—pancreatitis	0.000101	0.00201	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—SMO—pancreatitis	0.0001	0.002	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PTHLH—pancreatitis	0.0001	0.002	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPY—pancreatitis	9.9e-05	0.00197	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PPP3CA—pancreatitis	9.76e-05	0.00195	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—BDKRB2—pancreatitis	9.69e-05	0.00193	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPY—pancreatitis	9.68e-05	0.00193	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PPP3CA—pancreatitis	9.55e-05	0.00191	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CNR1—pancreatitis	9.51e-05	0.0019	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—BDKRB2—pancreatitis	9.48e-05	0.00189	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—SST—pancreatitis	9.36e-05	0.00187	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	9.33e-05	0.00186	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CNR1—pancreatitis	9.31e-05	0.00186	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—GCG—pancreatitis	9.19e-05	0.00183	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—SST—pancreatitis	9.16e-05	0.00183	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	9.13e-05	0.00182	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCL2—pancreatitis	8.99e-05	0.00179	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GCG—pancreatitis	8.99e-05	0.00179	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—KNG1—pancreatitis	8.82e-05	0.00176	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—BDKRB2—pancreatitis	8.8e-05	0.00176	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL2—pancreatitis	8.79e-05	0.00175	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CNR1—pancreatitis	8.64e-05	0.00172	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—KNG1—pancreatitis	8.63e-05	0.00172	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—BDKRB2—pancreatitis	8.61e-05	0.00172	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CNR1—pancreatitis	8.45e-05	0.00169	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GCG—pancreatitis	8.34e-05	0.00166	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GCG—pancreatitis	8.16e-05	0.00163	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—KNG1—pancreatitis	8.01e-05	0.0016	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—KNG1—pancreatitis	7.83e-05	0.00156	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SCT—pancreatitis	7.65e-05	0.00153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGG—pancreatitis	7.65e-05	0.00153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CASR—pancreatitis	7.65e-05	0.00153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CX3CL1—pancreatitis	7.5e-05	0.0015	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGG—pancreatitis	7.48e-05	0.00149	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SCT—pancreatitis	7.48e-05	0.00149	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CASR—pancreatitis	7.48e-05	0.00149	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCL5—pancreatitis	7.37e-05	0.00147	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CX3CL1—pancreatitis	7.34e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCK—pancreatitis	7.3e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MTNR1B—pancreatitis	7.3e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCL5—pancreatitis	7.21e-05	0.00144	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCK—pancreatitis	7.14e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MTNR1B—pancreatitis	7.14e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CNR2—pancreatitis	7.11e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—A2M—pancreatitis	7.11e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TACR1—pancreatitis	7.11e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CXCL8—pancreatitis	7.11e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCKAR—pancreatitis	7e-05	0.0014	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TACR1—pancreatitis	6.96e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—A2M—pancreatitis	6.96e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CNR2—pancreatitis	6.96e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CXCL8—pancreatitis	6.95e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCKAR—pancreatitis	6.84e-05	0.00137	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL5—pancreatitis	6.7e-05	0.00134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL5—pancreatitis	6.55e-05	0.00131	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGA—pancreatitis	6.5e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—pancreatitis	6.5e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGA—pancreatitis	6.36e-05	0.00127	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—pancreatitis	6.36e-05	0.00127	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SMO—pancreatitis	6.05e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTHLH—pancreatitis	6.05e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGB—pancreatitis	5.92e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTHLH—pancreatitis	5.92e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SMO—pancreatitis	5.92e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—pancreatitis	5.9e-05	0.00118	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CTRB2—pancreatitis	5.88e-05	0.00117	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGB—pancreatitis	5.79e-05	0.00115	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—pancreatitis	5.78e-05	0.00115	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP3CA—pancreatitis	5.77e-05	0.00115	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP3CA—pancreatitis	5.64e-05	0.00113	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SST—pancreatitis	5.53e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DUSP6—pancreatitis	5.48e-05	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SST—pancreatitis	5.41e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DUSP6—pancreatitis	5.36e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—BDKRB2—pancreatitis	5.2e-05	0.00104	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CNR1—pancreatitis	5.1e-05	0.00102	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FDX1—pancreatitis	5.1e-05	0.00102	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—BDKRB2—pancreatitis	5.09e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CNR1—pancreatitis	4.99e-05	0.000996	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GCG—pancreatitis	4.93e-05	0.000983	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GCG—pancreatitis	4.82e-05	0.000962	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH4—pancreatitis	4.74e-05	0.000946	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KNG1—pancreatitis	4.73e-05	0.000944	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KNG1—pancreatitis	4.63e-05	0.000923	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—pancreatitis	4.61e-05	0.00092	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—pancreatitis	4.51e-05	0.0009	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRSS1—pancreatitis	4.46e-05	0.000889	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFA—pancreatitis	4.35e-05	0.000868	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFA—pancreatitis	4.26e-05	0.000849	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PRSS3—pancreatitis	4.23e-05	0.000843	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PNLIP—pancreatitis	4.23e-05	0.000843	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL8—pancreatitis	4.02e-05	0.000801	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL5—pancreatitis	3.96e-05	0.000789	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL8—pancreatitis	3.93e-05	0.000784	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL5—pancreatitis	3.87e-05	0.000772	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—pancreatitis	3.87e-05	0.000772	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—XDH—pancreatitis	3.79e-05	0.000756	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—pancreatitis	3.78e-05	0.000755	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SPP1—pancreatitis	3.66e-05	0.000731	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL8—pancreatitis	3.65e-05	0.000728	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SPP1—pancreatitis	3.58e-05	0.000715	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CXCL8—pancreatitis	3.57e-05	0.000712	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH1B—pancreatitis	3.54e-05	0.000705	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—pancreatitis	3.49e-05	0.000696	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—pancreatitis	3.41e-05	0.000681	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—pancreatitis	3.24e-05	0.000647	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—pancreatitis	3.17e-05	0.000633	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NRAS—pancreatitis	2.93e-05	0.000584	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NRAS—pancreatitis	2.86e-05	0.000571	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G1B—pancreatitis	2.82e-05	0.000563	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—INS—pancreatitis	2.77e-05	0.000553	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—pancreatitis	2.73e-05	0.000544	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—A2M—pancreatitis	2.72e-05	0.000543	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—INS—pancreatitis	2.71e-05	0.00054	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—pancreatitis	2.67e-05	0.000532	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—KRAS—pancreatitis	2.52e-05	0.000502	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH2—pancreatitis	2.49e-05	0.000497	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—KRAS—pancreatitis	2.46e-05	0.000491	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MDM2—pancreatitis	2.3e-05	0.00046	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MDM2—pancreatitis	2.25e-05	0.00045	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL8—pancreatitis	2.15e-05	0.00043	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HRAS—pancreatitis	2.14e-05	0.000427	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL8—pancreatitis	2.11e-05	0.00042	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HRAS—pancreatitis	2.09e-05	0.000418	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CASP3—pancreatitis	2.06e-05	0.000411	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—pancreatitis	2.05e-05	0.000409	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CASP3—pancreatitis	2.02e-05	0.000402	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—pancreatitis	2e-05	0.0004	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GCG—pancreatitis	1.89e-05	0.000377	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRAS—pancreatitis	1.73e-05	0.000345	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRAS—pancreatitis	1.69e-05	0.000337	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—pancreatitis	1.61e-05	0.00032	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—pancreatitis	1.57e-05	0.000313	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KRAS—pancreatitis	1.49e-05	0.000297	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—pancreatitis	1.48e-05	0.000296	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KRAS—pancreatitis	1.46e-05	0.00029	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HRAS—pancreatitis	1.26e-05	0.000252	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HRAS—pancreatitis	1.24e-05	0.000247	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—pancreatitis	1.21e-05	0.000241	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—pancreatitis	1.18e-05	0.000236	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARG—pancreatitis	1.08e-05	0.000216	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INS—pancreatitis	1.06e-05	0.000212	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—pancreatitis	9.73e-06	0.000194	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—pancreatitis	8.51e-06	0.00017	CbGpPWpGaD
